Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210366737> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4210366737 abstract "<sec> <title>BACKGROUND</title> Youth account for a disproportionately high rates of new HIV infections in the United States (US). Despite intensive efforts to engage people living with HIV (PLWH) in the US, less than half of 13-24 years old achieve viral suppression. There is a clear and continued need for innovative behavioral programs that support optimizing adherence among young persons with HIV. </sec> <sec> <title>OBJECTIVE</title> There are three phases of this project. Phase 1 involves conducting focus groups in three cities (New York City, Chicago, and Houston) to obtain feedback from youth about an existing technology-based antiretroviral therapy (ART) adherence intervention. Phase 2 will be used to conduct beta testing with youth to refine and finalize the YouTHrive (YT) intervention. Phase 3 is a randomized controlled trial (RCT) to test the efficacy of the YouTHrive intervention among youth living with HIV (YLWH) in 6 US cities (Atlanta, New York City, Chicago, Houston, Philadelphia, and Tampa). </sec> <sec> <title>METHODS</title> In Phase 1, we will conduct six focus groups with approximately 8 youths (15-19 years old) and young adults (20-24 years old) each in three US cities to obtain: 1) feedback from YLWH about the “look and feel” and content of an existing adult-focused web-based ART adherence intervention; and 2) suggestions for adapting the intervention for YLWH similar to themselves. Phase 2 will involve collaboration with our technology development partner to update the existing intervention to include features and functionality recommended by YLWH in Phase 1. Phase 2 will conclude with beta testing with 12 participants to ensure that all features are working properly and function in a way that users can easily navigate. For Phase 3, we will enroll 300 YLWH in 6 US cities into a two-arm prospective randomized controlled trial (RCT). Participants randomized to the control condition will view a weekly newsletter for 20 weeks. The newsletter will be delivered via e-mail and will contain information on topics related to HIV, with the exception of ART adherence. Participants randomized to the YT intervention condition will be given access to the YT site for 20 weeks. Study assessments will occur at enrollment and 5, 8, and 11 months postenrollment. </sec> <sec> <title>RESULTS</title> Participant recruitment began in May 2017 for Phase 1 of the study. The data collection for Aim 3 is anticipated to end in April 2020. </sec> <sec> <title>CONCLUSIONS</title> The efficacy trial of the YT intervention will help to fill gaps in understanding about the efficacy of mobile interventions to improve ART adherence among at-risk populations. Other important questions remain to be addressed, including how best to incorporate virtual ART interventions into clinical care and when they are most effectively delivered. </sec> <sec> <title>CLINICALTRIAL</title> ClinicalTrials.gov (NCT03149757); University of North Carolina at Chapel Hill Institutional Review Board (16-3136). </sec>" @default.
- W4210366737 created "2022-02-08" @default.
- W4210366737 creator A5019215882 @default.
- W4210366737 creator A5019324425 @default.
- W4210366737 creator A5029323925 @default.
- W4210366737 creator A5031310041 @default.
- W4210366737 creator A5044815955 @default.
- W4210366737 creator A5064753304 @default.
- W4210366737 creator A5081519572 @default.
- W4210366737 date "2018-07-13" @default.
- W4210366737 modified "2023-09-26" @default.
- W4210366737 title "Connecting Youth and Young Adults to Optimize ART Adherence (YouTHrive): Protocol for a Randomized Controlled Trial (Preprint)" @default.
- W4210366737 cites W1967390644 @default.
- W4210366737 cites W1980327212 @default.
- W4210366737 cites W1980458358 @default.
- W4210366737 cites W1982363513 @default.
- W4210366737 cites W1991106348 @default.
- W4210366737 cites W1995576284 @default.
- W4210366737 cites W2005732969 @default.
- W4210366737 cites W2020213614 @default.
- W4210366737 cites W2035342780 @default.
- W4210366737 cites W2043705607 @default.
- W4210366737 cites W2046347837 @default.
- W4210366737 cites W2048533792 @default.
- W4210366737 cites W2061871804 @default.
- W4210366737 cites W2066440236 @default.
- W4210366737 cites W2075006538 @default.
- W4210366737 cites W2085381642 @default.
- W4210366737 cites W2085454038 @default.
- W4210366737 cites W2154112620 @default.
- W4210366737 cites W2155397747 @default.
- W4210366737 cites W2166738638 @default.
- W4210366737 cites W2336898845 @default.
- W4210366737 cites W2340311148 @default.
- W4210366737 cites W2531743908 @default.
- W4210366737 cites W2564699225 @default.
- W4210366737 cites W2806997439 @default.
- W4210366737 doi "https://doi.org/10.2196/preprints.11502" @default.
- W4210366737 hasPublicationYear "2018" @default.
- W4210366737 type Work @default.
- W4210366737 citedByCount "0" @default.
- W4210366737 crossrefType "posted-content" @default.
- W4210366737 hasAuthorship W4210366737A5019215882 @default.
- W4210366737 hasAuthorship W4210366737A5019324425 @default.
- W4210366737 hasAuthorship W4210366737A5029323925 @default.
- W4210366737 hasAuthorship W4210366737A5031310041 @default.
- W4210366737 hasAuthorship W4210366737A5044815955 @default.
- W4210366737 hasAuthorship W4210366737A5064753304 @default.
- W4210366737 hasAuthorship W4210366737A5081519572 @default.
- W4210366737 hasBestOaLocation W42103667372 @default.
- W4210366737 hasConcept C141071460 @default.
- W4210366737 hasConcept C15744967 @default.
- W4210366737 hasConcept C159110408 @default.
- W4210366737 hasConcept C168563851 @default.
- W4210366737 hasConcept C27415008 @default.
- W4210366737 hasConcept C2780665704 @default.
- W4210366737 hasConcept C3013748606 @default.
- W4210366737 hasConcept C512399662 @default.
- W4210366737 hasConcept C71924100 @default.
- W4210366737 hasConcept C74909509 @default.
- W4210366737 hasConceptScore W4210366737C141071460 @default.
- W4210366737 hasConceptScore W4210366737C15744967 @default.
- W4210366737 hasConceptScore W4210366737C159110408 @default.
- W4210366737 hasConceptScore W4210366737C168563851 @default.
- W4210366737 hasConceptScore W4210366737C27415008 @default.
- W4210366737 hasConceptScore W4210366737C2780665704 @default.
- W4210366737 hasConceptScore W4210366737C3013748606 @default.
- W4210366737 hasConceptScore W4210366737C512399662 @default.
- W4210366737 hasConceptScore W4210366737C71924100 @default.
- W4210366737 hasConceptScore W4210366737C74909509 @default.
- W4210366737 hasLocation W42103667371 @default.
- W4210366737 hasLocation W42103667372 @default.
- W4210366737 hasOpenAccess W4210366737 @default.
- W4210366737 hasPrimaryLocation W42103667371 @default.
- W4210366737 hasRelatedWork W108272740 @default.
- W4210366737 hasRelatedWork W2052539084 @default.
- W4210366737 hasRelatedWork W2507295142 @default.
- W4210366737 hasRelatedWork W2507619851 @default.
- W4210366737 hasRelatedWork W2748952813 @default.
- W4210366737 hasRelatedWork W2899084033 @default.
- W4210366737 hasRelatedWork W3159250744 @default.
- W4210366737 hasRelatedWork W4232135538 @default.
- W4210366737 hasRelatedWork W4256514411 @default.
- W4210366737 hasRelatedWork W4292236216 @default.
- W4210366737 isParatext "false" @default.
- W4210366737 isRetracted "false" @default.
- W4210366737 workType "article" @default.